4,5,6,7-tetrahydrothieno[3,2-c]pyridine,hydrochloride

We are 4,5,6,7-tetrahydrothieno[3,2-c]pyridine,hydrochloride CAS:28783-41-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4,5,6,7-tetrahydrothieno[3,2-c]pyridine,hydrochloride
CAS.NO:28783-41-7
Synonyms:4,5,6,7-tetrahydrothieno[3,2-c]pyridine,hydrochloride
4,5,6,7-Tetrahydrothieno[3,2-c]pyridin-5-ium chloride
 
Physical and Chemical Properties:
Density 1.143g/cm3
Boiling Point 242.9ºC at 760 mmHg
Melting Point 212-215°C
Molecular Formula C7H10ClNS
Molecular Weight 175.679
Flash Point 100.7ºC
 
Specification:
Appearance:White or off-white powder
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Clopidogrel and Prasugrel.

4,5,6,7-tetrahydrothieno[3,2-c]pyridine,hydrochloride


Related News: Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.4-(Trifluoromethoxy)benzyl bromide By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.2-cloro-5-clorometilpiridina CAS:70258-18-3 Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.3272-08-0 Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.

Related Products
Product Name
5-Chloro-4-fluoro-1H-indole-2-carboxylic acid View Details
3-Ureidopropyltriethoxysilane Cas:23779-32-0 View Details
arsorosomethane View Details
2,6-Dichloronicotinic acid manufacturer 3-Amino-4-methoxybenzanilide manufacturer N-(4-Oxocyclohexyl)acetamide manufacturer BASIC RED 5 Cas:553-24-2 manufacturer Chloromethyl Trimethoxysilane Cas:5926-26-1 manufacturer